This issue of Clinics in Laboratory Medicine, guest edited by Dr. A. Zara Herskovits, will cover Laboratory Testing for Neurologic Disorders. This issue is one of four selected each year by our Editor-in-Chief, Dr. Milenko Jovan Tanasijevic. Topics discussed in this issue will include: molecular approach to diagnostic testing for children with developmental delay and congenital anomalies, proteopathic and seeding assays (such as RT-QUIC), genetic testing for ALS and FTD, Diagnostic and prognostic testing for Alzheimer’s disease, confounds in the interpretation of paraneoplastic antibody panels, Review of neurologic disease sendout testing at an academic medical center, development of new diagnostic tests for neurologic disorders, assuring quality in laboratory testing for sendout reference tests, diagnostic testing for patients with spinal muscular atrophy, among others.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Preface - p. ix 8. Optimizing Genetic Diagnosis of Neurodevelopmental Disorders in the Clinical Setting - p. 231 9. Proteopathic Seed Amplification Assays for Neurodegenerative Disorders - p. 257 10. Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management - p. 271 11. Diagnostic and Prognostic Laboratory Testing for Alzheimer Disease - p. 289 12. Confounders in the Interpretation of Paraneoplastic and Neuronal Autoantibody Panels - p. 305 13. Reference Laboratory Testing for Neurologic Disorders - p. 317 14. The Development of New Diagnostic Tests for Neurologic Disorders in the Commercial Laboratory Environment - p. 331 15. Something’s Lost and Something’s Gained: Seeing Reference Laboratory Quality from Both Sides, Now - p. 341 16. Diagnostic Testing for Patients with Spinal Muscular Atrophy - p. 357 17. Cerebrospinal Fluid Testing for Multiple Sclerosis - p. 369
This issue of Clinics in Laboratory Medicine, guest edited by Dr. A. Zara Herskovits, will cover Laboratory Testing for Neurologic Disorders. This issue is one of four selected each year by our Editor-in-Chief, Dr. Milenko Jovan Tanasijevic. Topics discussed in this issue will include: molecular approach to diagnostic testing for children with developmental delay and congenital anomalies, proteopathic and seeding assays (such as RT-QUIC), genetic testing for ALS and FTD, Diagnostic and prognostic testing for Alzheimer’s disease, confounds in the interpretation of paraneoplastic antibody panels, Review of neurologic disease sendout testing at an academic medical center, development of new diagnostic tests for neurologic disorders, assuring quality in laboratory testing for sendout reference tests, diagnostic testing for patients with spinal muscular atrophy, among others.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Preface - p. ix 8. Optimizing Genetic Diagnosis of Neurodevelopmental Disorders in the Clinical Setting - p. 231 9. Proteopathic Seed Amplification Assays for Neurodegenerative Disorders - p. 257 10. Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management - p. 271 11. Diagnostic and Prognostic Laboratory Testing for Alzheimer Disease - p. 289 12. Confounders in the Interpretation of Paraneoplastic and Neuronal Autoantibody Panels - p. 305 13. Reference Laboratory Testing for Neurologic Disorders - p. 317 14. The Development of New Diagnostic Tests for Neurologic Disorders in the Commercial Laboratory Environment - p. 331 15. Something’s Lost and Something’s Gained: Seeing Reference Laboratory Quality from Both Sides, Now - p. 341 16. Diagnostic Testing for Patients with Spinal Muscular Atrophy - p. 357 17. Cerebrospinal Fluid Testing for Multiple Sclerosis - p. 369
